# Effect of PMSCs and Their Secretome for the Treatment of GvHD

> **NCT06469411** · PHASE3 · COMPLETED · sponsor: **Tabriz University of Medical Sciences** · enrollment: 60 (actual)

## Conditions studied

- GVHD

## Interventions

- **BIOLOGICAL:** Secretome (set of substances released from the cell to its surroundings) of mesenchymal stem cells retrieved from the placenta (containing 400 microgram protein/ milliliter)
- **OTHER:** 4 cc distilled water dissolved in albumin 20%

## Key facts

- **NCT ID:** NCT06469411
- **Lead sponsor:** Tabriz University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-01
- **Primary completion:** 2023-06-30
- **Final completion:** 2024-01-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-06-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06469411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06469411, "Effect of PMSCs and Their Secretome for the Treatment of GvHD". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06469411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*